These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2014542)

  • 1. Additive inhibition of afferent and efferent immunological responses of human peripheral blood mononuclear cells by verapamil and cyclosporine.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1991 Apr; 51(4):851-7. PubMed ID: 2014542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract]   [Full Text] [Related]  

  • 4. The additive effect of certain drugs on the cyclosporine A inhibition of human T-cell proliferation. Studies using theophyllamine, warfarin, verapamil and dipyridamol.
    Bruserud O
    APMIS; 1990 Dec; 98(12):1070-6. PubMed ID: 2282202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that the antiproliferative effect of verapamil on afferent and efferent immune responses is independent of calcium channel inhibition.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplantation; 1992 Oct; 54(4):681-5. PubMed ID: 1412759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunosuppressive properties of enisoprost and a 5-lipoxygenase inhibitor (SC-45662).
    Weir MR; Li XW; Gomolka D; Peppler R; O'Bryan-Tear CG; Moran MA
    Transplantation; 1991 Dec; 52(6):1053-7. PubMed ID: 1750068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
    Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
    Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
    Hess AD; Bright EC
    Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar effects of cyclosporine and verapamil on lymphokine, interleukin 2 receptor, and proto-oncogene expression.
    Walz G; Zanker B; Wieder K; Hadro E; Moscovitch-Lopatin M; Smith BR; Strom TB
    Transplantation; 1989 Feb; 47(2):331-4. PubMed ID: 2645720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory activity of cyclosporine is dependent on the activating signal(s) provided to T cells.
    Suthanthiran M
    J Pediatr; 1987 Dec; 111(6 Pt 2):1008-11. PubMed ID: 2960793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers inhibit cellular uptake of thymidine, uridine and leucine: the incorporation of these molecules into DNA, RNA and protein in the presence of calcium channel blockers is not a valid measure of lymphocyte activation.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Immunopharmacology; 1993; 25(1):75-82. PubMed ID: 7686541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine inhibits protein kinase C-dependent signals in human peripheral blood lymphocytes.
    McMillen MA; Schaefer HA; MacArthur JD; Adrian TA; Modlin IM
    J Surg Res; 1989 Apr; 46(4):292-5. PubMed ID: 2523008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of verapamil on the IL-2 binding to its active receptor and on the release of IL-2 receptor by activated PBMC.
    Mikhail N; Raska K; Raskova J; Degiannis D
    Immunopharmacology; 1993; 25(1):29-36. PubMed ID: 8320080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of verapamil on cellular uptake, organ distribution, and pharmacology of cyclosporine.
    McMillen MA; Baumgarten WK; Schaefer HC; Mitchnick E; Fuortes M; Holman MJ; Tesi RJ
    Transplantation; 1987 Sep; 44(3):395-401. PubMed ID: 3629688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs.
    Klimecki WT; Taylor CW; Dalton WS
    J Clin Immunol; 1995 May; 15(3):152-8. PubMed ID: 7559918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster formation of canine dendritic cells and lymphocytes is calcium dependent and not inhibited by cyclosporine.
    Aprile J; Gerhard-Miller L; Deeg HJ
    Exp Hematol; 1990 Jan; 18(1):32-6. PubMed ID: 2105228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine A and prednisolone inhibit lectin- and alloantigen-induced release of sCD8: correlation with proliferative responses.
    Kim HS; Degiannis D; Raskova J; Raska K
    Clin Immunol Immunopathol; 1991 Jul; 60(1):27-39. PubMed ID: 1904329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of cyclosporine on ornithine decarboxylase induction with mitogens, antigens, and lymphokines.
    Fidelus RK; Laughter AH; Twomey JJ; Taffet SM; Haddox MK
    Transplantation; 1984 Apr; 37(4):383-7. PubMed ID: 6231749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro.
    Kahan BD; Gibbons S; Tejpal N; Stepkowski SM; Chou TC
    Transplantation; 1991 Jan; 51(1):232-9. PubMed ID: 1987692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.